Connection

Olga Brawman-Mintzer to Antipsychotic Agents

This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Antipsychotic Agents.
Connection Strength

0.886
  1. Role of atypical antipsychotics in the treatment of generalized anxiety disorder. CNS Drugs. 2014 Jun; 28(6):519-33.
    View in: PubMed
    Score: 0.382
  2. Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychiatry. 2005 Oct; 66(10):1321-5.
    View in: PubMed
    Score: 0.209
  3. New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27.
    View in: PubMed
    Score: 0.193
  4. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2011 Jan; 26(1):11-24.
    View in: PubMed
    Score: 0.075
  5. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry. 1996; 57 Suppl 7:55-63; discussion 73-5.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.